Brixton Biosciences

Cambridge, MA · Founded 2019 · Privately Held (backing)

Developer of a biomedical neuromodulation therapy designed to sustain pain relief and support mobility. Brixton Biosciences is based in Cambridge, MA and was founded in 2019. It has raised $41 million.

Last price · $/share

—

Implied valuation

—

Total raised

$41.0M

Last round

—

How much has Brixton Biosciences raised?

$41.0Macross 0 recorded rounds

Free account

More of Brixton Biosciences with a free account

·The complete investor list: 11 names
·Watch Brixton Biosciences: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Brixton Biosciences investors

11 investors are on record for Brixton Biosciences, including National Institutes of Health, SV Health Investors, FemHealth Ventures and Schooner Capital. By type, the record holds 2 venture capital firms, 2 family offices and 1 growth equity firm.

For fundraisers

Raising for a company like Brixton Biosciences?

11 investors have backed Brixton Biosciences.

See all 11 investors →

Frequently asked about Brixton Biosciences

How much has Brixton Biosciences raised?: Brixton Biosciences has raised $41.0M in total across 0 recorded funding rounds.